COV.V Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: June 26, 2025

Report Source: 2025 2nd Quarter Report

Analyst's Ratings for Covalon Technologies Ltd (COV.V)

Based on 9 analysts giving stock ratings to Covalon Technologies Ltd in the past 3 months

Strong
Sell
SellHoldBuyStrong
Buy
Strong Buy
33
Buy
56
Hold
11
Sell
0
Strong Sell
0
Covalon Technologies Ltd

Covalon Technologies Ltd. Stock Analysis COV.V

Canada Health Care Nano Cap Report:
Covalon Technologies Ltd. engages in the research, development, manufacturing, and marketing of patent-protected medical products. The company is headquartered in Mississauga, Ontario. The company went IPO on 2004-09-03. The firm's solutions are designed for patients and made for care providers. The firm leverages its patented medical technology platforms and expertise in two ways: by developing products that are sold under Covalon's name, and by developing and commercializing medical products for other medical companies under development and license contracts. The firm has three proprietary platform technologies that have the potential to be developed into a number of medical devices and products: Collagen matrix, Antimicrobial silicone adhesive and Medical coatings. Its product type includes advanced wound care, antimicrobial dressings, collagen dressings, IV dressings, and perioperative dressings. Its brands include ColActive PLUS, CovaClear, CovaView, CovaWound, IV Clear, SurgiClear, and VALGuard.
Read More

Covalon Technologies Ltd (COV.V) Chart

Key Statistics of Covalon Technologies Ltd (COV.V)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

CAD1.88CAD1.95

Today's Open

CAD1.91

Volume

6655.00

P/E Ratio (TTM)

26.17

52 Week Range

CAD1.55CAD3.10

Market Cap

51.37M

Avg. Volume

6917.52

Dividend Yield

-

Financial Metrics & Statements of Covalon Technologies Ltd (COV.V)

Community-Curated Collections with Covalon Technologies Ltd (COV.V) ( With COV.V )

View All

Community-Curated Collections are thoughtfully selected groups of stocks or assets, curated by investors and experts based on shared themes, values, or investment strategies.

FAQ's for Covalon Technologies Ltd (COV.V)

  • According to Musaffa’s Shariah screening methodology, Covalon Technologies Ltd (COV.V) is currently classified as NOT HALAL as of June 2025. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Disclaimer

The content provided on this website is intended solely for informational and educational purposes. Musaffa is a technology, data, education, and research company. We are not licensed financial service provider by the authorized relevant financial service regulator in India or any other regulatory government body, and we do not offer or facilitate any trading, brokerage, investment, or financial advisory services. We do not deliberately target an audience seeking financial services.

By accessing this website, you acknowledge and confirm that you are seeking information relating to Musaffa of your own accord, and that there has been no form of solicitation, advertisement, or inducement by Musaffa or its members. Musaffa shall not be liable for the consequences of any action taken by relying on the material or information provided on this website. The contents of this website are the intellectual property of Musaffa.